RxDoctor Payments Data

Elise Bruce

Family · Crofton, MDNPI 1902589823

Payments from drug & device makers

$894in general payments, 2019–2025

Across 32 payments — averaging $27.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$173
  • Sobi, Inc$120
  • Medtronic$104
  • Lilly USA, LLC$78
  • AbbVie$71
  • GSK$50
  • plus $298 from 12 others

What the payments were for

  • Food & beverage$894100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$894 in reported general payments places this provider in the 65th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$41,035
Medicare patients
117
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide12$12,441
OzempicSemaglutide12$12,251
Rosuvastatin Calcium34$1,035
Atorvastatin Calcium46$557
Bupropion XlBupropion Hcl16$394
Albuterol Sulfate HfaAlbuterol Sulfate13$354
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide13$306
Fluticasone Propionate26$295
Pantoprazole Sodium12$277
Levothyroxine Sodium28$243
Montelukast Sodium14$236
Famotidine21$227
Tamsulosin Hcl12$221
Metoprolol Succinate16$185
Amlodipine Besylate34$161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$78$12,44112 claims
Novo NordiskOzempic$173$12,25112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,843 family providers in Maryland.

Other family in Crofton

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →